- Home
- SNY vs COP Comparison
SNY vs COP Comparison
Compare SNY & COP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNY | COP |
|---|---|---|
| Founded | 1994 | 1917 |
| Country | France | United States |
| Employees | 74846 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.5B | 146.5B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | SNY | COP |
|---|---|---|
| Price | $42.85 | $116.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 23 |
| Target Price | $58.00 | ★ $123.65 |
| AVG Volume (30 Days) | 3.1M | ★ 5.9M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.47% | 2.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.00 |
| Revenue | N/A | ★ $58,944,000,000.00 |
| Revenue This Year | $3.49 | $6.88 |
| Revenue Next Year | $6.10 | N/A |
| P/E Ratio | ★ $6.14 | $64.63 |
| Revenue Growth | N/A | ★ 7.67 |
| 52 Week Low | $40.89 | $85.59 |
| 52 Week High | $52.68 | $135.87 |
Technical Indicators
Market Signals| Indicator | SNY | COP |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 54.18 |
| Support Level | $42.64 | $112.94 |
| Resistance Level | $43.48 | $122.13 |
| Average True Range (ATR) | 0.71 | 2.67 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 45.47 | 46.21 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About COP ConocoPhillips
ConocoPhillips is a US-based independent exploration and production firm. Its operations are primarily in Alaska and the Lower 48, with footprints in Canada, Europe, Asia-Pacific, the Middle East, and Africa. It also has substantial integrated LNG production and marketing activities across geographies.